Expression of integrin receptors on 45 clinical neuroblastoma specimens
暂无分享,去创建一个
D. Frappaz | E. Goillot | V. Combaret | E. Tabone | M. Favrot | E. Bouffet | P. Thiesse | T. Philip | P. Lutz | A. Thyss | D. Dolbeau
[1] E. Goillot,et al. Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens , 1991, International journal of cancer.
[2] D. Elder,et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.
[3] S. Kennel,et al. Integrin (α6/β4) Expression in Human Lung Cancer as Monitored by Specific Monoclonal Antibodies , 1990 .
[4] S. Albelda,et al. Integrins and other cell adhesion molecules , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] A. Sonnenberg,et al. The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin , 1990, The Journal of cell biology.
[6] A. Sonnenberg,et al. Integrin recognition of different cell-binding fragments of laminin (P1, E3, E8) and evidence that alpha 6 beta 1 but not alpha 6 beta 4 functions as a major receptor for fragment E8 , 1990, The Journal of cell biology.
[7] S. Dedhar,et al. Isolation of a novel integrin receptor mediating Arg-Gly-Asp-directed cell adhesion to fibronectin and type I collagen from human neuroblastoma cells. Association of a novel beta 1-related subunit with alpha v , 1990, The Journal of cell biology.
[8] S. Bodary,et al. The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. , 1990, The Journal of biological chemistry.
[9] E. Ruoslahti,et al. A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). , 1990, The Journal of biological chemistry.
[10] W. Carter,et al. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells , 1990, Journal of Cell Biology.
[11] F. Giancotti,et al. Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells , 1990, Cell.
[12] R. Brentani,et al. Independent prognostic value of laminin receptor expression in breast cancer survival. , 1990, Cancer research.
[13] M. Elices,et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.
[14] J W Smith,et al. Integrin (alpha v beta 3)-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor. , 1990, The Journal of biological chemistry.
[15] S. Dedhar,et al. Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes , 1990, The Journal of cell biology.
[16] E. Ruoslahti,et al. Alpha 2 beta 1 integrins from different cell types show different binding specificities. , 1990, The Journal of biological chemistry.
[17] Richard O. Hynes,et al. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α 4 β 1 , 1990, Cell.
[18] M. Elices,et al. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[19] V. Combaret,et al. Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols. , 1989, European journal of cancer & clinical oncology.
[20] F. Walsh,et al. Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma , 1989, International journal of cancer.
[21] R. Warnke,et al. Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. , 1989, American journal of clinical pathology.
[22] V. Combaret,et al. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. , 1989, British Journal of Cancer.
[23] A. Bernard,et al. Suppressor effects and cyclic AMP accumulation by the CD29 molecule of CD4+ lymphocytes , 1989, Nature.
[24] J. A. Mourik,et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex , 1989 .
[25] R. Kramer,et al. Identification of integrin collagen receptors on human melanoma cells. , 1989, The Journal of biological chemistry.
[26] E. Ruoslahti,et al. A neuroectoderm-associated ganglioside participates in fibronectin receptor-mediated adhesion of germinal cells to fibronectin. , 1989, Developmental biology.
[27] R. Timpl,et al. Domains of laminin with growth-factor activity , 1989, Cell.
[28] A. Sonnenberg,et al. Laminin receptor on platelets is the integrin VLA-6 , 1988, Nature.
[29] C. R. Pinkerton,et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. , 1988, Progress in clinical and biological research.
[30] W. Carter,et al. Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin correspond to VLA‐2 and VLA‐3 in the VLA family of heterodimers , 1988, Journal of cellular biochemistry.
[31] M. Humphries,et al. Neurite extension of chicken peripheral nervous system neurons on fibronectin: relative importance of specific adhesion sites in the central cell-binding domain and the alternatively spliced type III connecting segment , 1988, The Journal of cell biology.
[32] D. Cheresh,et al. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. , 1987, The Journal of biological chemistry.
[33] W. Carter,et al. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits , 1987, The Journal of cell biology.
[34] T. Triche,et al. Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. , 1987, The American journal of pathology.
[35] J. Strominger,et al. Characterization of the cell surface heterodimer VLA-4 and related peptides. , 1987, The Journal of biological chemistry.
[36] M. Hemler,et al. The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit. , 1987, The Journal of biological chemistry.
[37] J. Zucker,et al. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] V. Woods,et al. Very late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens , 1986, The Journal of experimental medicine.
[39] T. Carey,et al. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. , 1986, Cancer research.
[40] H. Sather,et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.
[41] E. Ruoslahti,et al. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor , 1985, Cell.
[42] H. B. Marsden,et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.
[43] L. Hochholzer,et al. Ganglioneuroblastoma of the posterior mediastinum: A clinicopathologic review of 80 cases , 1981, Cancer.
[44] L. Culp,et al. Requirement for two different cell-binding domains in fibronectin for neurite extension of neuronal derivative cells. , 1990, Journal of cell science.
[45] R A Ross,et al. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. , 1989, Cancer research.